title: GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population.
abstract: OBJECTIVE
  It has been suggested that the polymorphic variation of GLUT1 glucose transporter may contribute to genetic susceptibility to type 2 diabetes in some populations. We have evaluated the GLUT1-XbaI polymorphism in an association study of a Caucasian Mediterranean population and its role in the susceptibility to displaying either microangiopathic complications or any of the risk factors associated with type 2 diabetes.
  
  
  METHODS
  A total of 193 type 2 diabetic patients (104 women and 89 men, 31-82 years of age, diabetes duration 13.2 +/- 6.2 years) and 90 healthy subjects (48 women and 42 men, 20-72 years of age) were recruited for the association study. For the evaluation of nephropathy and retinopathy, type 2 diabetic patients were matched with those not having microangiopathic complications.
  
  
  RESULTS
  Genotypic or allelic frequencies did not differ significantly between controls and type 2 diabetic patients. Regarding the distribution of clinical or metabolic parameters according to GLUT1 genotype, patients with X1X1 genotype tended to have higher diastolic blood pressure levels compared with the remaining genotypes (P = 0.008). There were no differences in genotypic or allelic distribution among patients for either the presence or absence of retinopathy or nephropathy.
  
  
  CONCLUSIONS
  We conclude that GLUT1 loci did not contribute significantly to type 2 diabetes in this cohort and is not a determinant for cardiovascular risk factors or chronic microangiopathic complications associated with type 2 diabetes. The weak association with diastolic hypertension must be confirmed in other populations.
authors.affiliation: Internal Medicine Department, Hospital Universitari Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain. crisgf@galenics.com
authors.forename: C
authors.initials: C
authors.lastname: Gutierrez
authors.forename: J
authors.initials: J
authors.lastname: Vendrell
authors.forename: R
authors.initials: R
authors.lastname: Pastor
authors.forename: M
authors.initials: M
authors.lastname: Broch
authors.forename: C
authors.initials: C
authors.lastname: Aguilar
authors.forename: C
authors.initials: C
authors.lastname: Llor
authors.forename: I
authors.initials: I
authors.lastname: Simon
authors.forename: C
authors.initials: C
authors.lastname: Richart
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001794:Blood Pressure / Q000502:physiology; D002318:Cardiovascular Diseases / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology* / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000150:complications*; D005838:Genotype; D051272:Glucose Transporter Type 1; D006801:Humans; D008297:Male; D008522:Mediterranean Sea; D008833:Microcirculation / Q000502:physiology; D008875:Middle Aged; D009004:Monosaccharide Transport Proteins / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000235:genetics*; D012150:Polymorphism, Restriction Fragment Length; D012307:Risk Factors; D012727:Sex Characteristics
chemical_list: D051272:Glucose Transporter Type 1; D009004:Monosaccharide Transport Proteins; C495677:SLC2A1 protein, human